CelluBridge

CelluBridge is a plant-derived cellulose scaffold designed for the treatment of acute and chronic spinal cord injuries. Developed by Spiderwort Inc., the biomaterial is engineered to mimic the physical and mechanical properties of the spinal cord's extracellular matrix, providing a structural framework that supports the regrowth of damaged axons and facilitates neural tissue regeneration. The scaffold is non-immunogenic and biocompatible, allowing it to integrate into the injury site without triggering a significant immune response. CelluBridge has received the FDA's Breakthrough Device Designation, highlighting its potential to address a significant unmet medical need in neuroregeneration by providing a guidance structure for cellular repair.

Brand names

CelluBridge

Other names

SpideRXSpiderwort cellulose scaffold